Connection

Piero Olliaro to United States Food and Drug Administration

This is a "connection" page, showing publications Piero Olliaro has written about United States Food and Drug Administration.
  1. Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years. PLoS Negl Trop Dis. 2018 11; 12(11):e0006837.
    View in: PubMed
    Score: 0.109
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.